Press Releases from Kuick Resarch (925 total)
FDA grants orphan drug designation to Sangamo’s SB-318
Sangamo Biosciences Inc., a biopharmaceutical company announced that US Food and Drug Administration has granted orphan drug designation to its genome editing candidate, SB-319 for…
Yeliva receives FDA orphan drug status for cholangiocarcinoma
US Food and Drug Administration has granted orphan drug designation to Yeliva a first-in-class, orally administered, sphingosine kinase-2 selective inhibitor with anticancer and anti-inflammatory activities,…
EU Commission grants orphan drug designation to Abeona’s EB101 Gene Therapy
Abeona Therapeutics, a leading pharmaceutical company recently announced that European Medicine Agency has granted orphan drug designation to its leading gene therapy candidate, EB 101…
ChemoCentryx announces FDA orphan drug designation for Avacopan in the Treatment …
US Food and Drug Administration (FDA) have announced orphan drug designation for chemocentryx’s leading product candidate, avacopan for the treatment of patients suffering with Debilitating…
Dynport’s Plague vaccine receives orphan drug status from FDA
DynPort Vaccine Company LLC (DVC), a subsidiary of CSRA, announced that its plague vaccine has received orphan drug designation from US Food and Drug Administration.…
Boehringer Ingelheim’s investigational anti-CD33 monoclonal antibody BI 836858 …
US Food and Drug Administration has announced orphan drug designation for Boehringer Ingelheim’s investigational anti-CD33 monoclonal antibody…
EMA grants orphan drug designation to Epidiolex® from GW Pharmaceuticals
GW Pharmaceuticals has announced that European Medicine Agency has granted orphan drug designation to its leading product candidate, Epidiolex® (cannabidiol or CBD) for effective treatment…
CAEL-101 from Fortress Biotech (FBIO) Receives Orphan Drug Designations for Amyl …
U.S. Department of Health & Human Services has confirmed the transfer of two U.S. Food and Drug Administration (FDA) Orphan Drug Designations for CAEL-101 (also…
Gamida Cell Announces orphan drug designation for NiCord®
European Medicine Agency (EMA) has announced orphan drug status for NiCord® developed by Gamida cell, a leader in cellular and immune therapies for the treatment…
EU Commission grants orphan drug status to ZX008 in Lennox Gastaut Syndrome
Zogenix Inc., a leading biopharmaceutical company dedicated to develop therapies to treat orphan and central nervous system (CNS) disorders, declared that European Commission has announced…
FDA grants orphan drug designation to EnGeneIC for Targeted EDV™ Nanocells to …
US Food and Drug Administration has announced orphan drug status for EGFR-targeted, doxorubicin-loaded EDV Nano cells for the treatment of glioblastoma multiforme (GBM) the most…
FDA announces orphan drug status for aNK Natural Killer Cell Therapy in Merkel C …
NantKwest, Inc. has recently received orphan drug designation from US Food and Drug Administration (FDA) for its leading drug candidate, activated natural killer (aNK) cell…
EMA grants orphan drug designation to aTyr Pharma for the Treatment of Limb Gird …
European Medicine Agency has granted orphan drug designation to aTyr Pharma, Inc. (LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics…
FDA grants orphan drug designation to Miragen Therapeutics
Miragen Therapeutics, a leading biopharmaceutical company has announced that US Food and Drug Administration have granted orphan drug designation to its novel product, MRG-106 for…
Prometic’s PBI-4050 receives FDA orphan drug status for Alström Syndrome
US Food and Drug Administration has announced orphan drug designation to orally active, anti-fibrotic, lead drug candidate, PBI-4050 Drug, for the treatment of Alstrӧm Syndrome…
European Union grants orphan drug designation to LSK BioPharma’s Apatinib
LSK BioPharma, a leading biopharmaceutical company announced that company’s novel small-molecule angiogenesis inhibitor, Apatinib is awarded with orphan drug designation from European Commission for the…
FDA grants orphan drug status to Sapience Therapeutics (ST-36)
Sapience Therapeutics, a leading biotechnonology company dedicated to develop therapies for complicated cancer cases, declared that US Food and Drug Administration (FDA) has awarded company’s…
Opko receives orphan drug designation for CUR-1916 in Dravet Syndrome
Opko Health Inc., a leading pharmaceutical company has announced that US Food and Drug Administration has granted orphan drug designation for company’s oligonucleotide-based AntagoNAT (CUR-1916)…
FDA orphan drug status given to Exelixis, Inc. (EXEL) for the Treatment of Hepat …
US Food and Drug Administration have granted orphan drug designation to Exelixis’ novel product cabozantinib for the treatment of hepatocellular carcinoma (HCC). A pivotal phase…
Annamycin from Moleculin receives orphan drug status for the Treatment of Acute …
Moleculin Biotech, Inc, a preclinical pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based on license agreements with The…
FDA grants orphan drug designation to SB-913 Genome Editing Treatment for MPS II
Sangamo Therapeutics, Inc., a leading pharmaceutical company dedicated to develop gene therapies and therapeutic genome editing has recived orphan drug designation from US Food and…
DLBCL receives FDA orphan drug designation for eFT508
US Food and Drug Administration has announced orphan drug designation to eFT508, a highly selective inhibitor of MNK1 and MNK2 for the treatment of diffuse…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN)…
Immune design receives orphan drug status for G100 Intratumoral therapy Candidat …
Immune Design, a biopharmaceutical company focused on developing drugs and therapies for oncology has declared receipt of orphan drug designation by US Food and Drug…
FDA grants orphan drug status to ZW25 for Gastric Cancer Treatment
US Food and Drug Administration has awarded orphan drug designation to Zymework’s leading product candidate, ZW25 for the treatment of gastric cancer and cancer of…
Protalex receives orphan drug designation for ITP
Protalex, a biopharmaceutical company dedicated to develop orphan drug or therapies for the effective treatment of patients with rare diseases, has recently announced that its…
Minoryx therapeutics announces orphan drug designation for MIN-102
Minoryx Theapeutics, a leading drug development company focused on developing orphan drugs for rare diseases recently, announced that US Food and Drug Administration (FDA) has…
Tasquinimod from Active Biotech receives orphan drug status for multiple myeloma
US Food and Drug Administrations has granted orphan drug designation to Tasquinimod, investigational novel agent developed by Active Biotech, a leading biopharmaceutical company for the…
NantCell receives FDA orphan drug status for Ganitumab Monoclonal Antibody Thera …
NantCell, Inc., part of the NantWorks ecosystem of companies, has been granted orphan drug designation from US Food and Drug Administration (FDA) for the company’s…
EU grants orphan drug status to Strekin’s STR001 for Sudden Sensorineural Hear …
European Medicine Agency (EMA) has granted orohan drug designation to Sterkin AG, a clinical stage biopharmaceutical company’s development candidate STR001 for the treatment of patients…
China Healthcare Market Analysis Sales Revenue Opportunity Report
Healthcare system in China is witnessing series of transformation driven by government backed reform process and increasing private sector participation. Although China healthcare market is…
India Biosimilar Market Analysis Sales Revenue Opportunity Report
As the number of patent expiries of biologic drugs is increasing, Indian companies are developing biosimilar manufacturing capabilities. Firms are developing their capabilities by either…
Private Hospital Services Market In India Sales Revenue Opportunity Report
Over the years the share of the private sector in the provision of health care delivery has increased to more than 75% of all outpatient…
India Cosmetic Surgery Market Sales Revenue Opportunity Report 2016
India is viewed as one of the most progressive countries for cosmetic surgical procedures and this trend is expected to continue in the near future.…
India Genetic Testing Market Sales Revenue Opportunity Report
India is witnessing an accelerating shift towards the prevalence of non-communicable diseases, having secured third position in congenital malformations and genetic disorders as the commonest…
India Stem Cell Banking Market Sales Revenue Opportunity Report
Stem Cell Banking has emerged as new opportunity of healthcare services provider in Indian market. The market is still in nascent stage of development and…
India Specialty Clinics Market Sales Revenue Opportunity Report 2016
Specialty clinics are emerging out of the general hospitals as a universal trend. Globally, niche specialties are being catered to by specialty clinics. The share…
Russia Clinical Trial Market Sales Revenue Opportunity Report Analysis
The Russian clinical trial market accounts for a significant share in the global clinical trial market. The country has got the population and the prevalence…
Singapore Clinical Trial Market Sales Revenue Opportunity Report Analysis
Singapore has off late come to become the nucleus of clinical research activities in the Asia-Pacific region. The country is a natural hub for manufacturers…
Brazil Medical Device Market Sales Revenue Opportunity Report 2018
Being one of the largest economies in Latin America and being visualized as one of the key upcoming healthcare hubs, Brazil has come a long…
Saudi Arabia Medical Device Market Sales Revenue Opportunity Report 2018
Accounting for nearly 50% of the total Middle East market, the Saudi Arabian medical devices market is estimated around US$ 1.1 Billion in 2013 and…
Indian In Vitro Diagnostics Market Sales Revenue Opportunity Report 2018
The Indian IVD market is valued at more than US$ 500 Million, and is expected to surpass US$ 1.5 Billion by 2018 growing steady at…
India IVF Treatment Market Sales Revenue Opportunity Report 2018
India has a large population of 1.22 Billion people and infertility in the country is rising at a rapid rate (about 30 Million couples suffer…
UAE Diabetes Market Opportunity Sales Revenue Opportunity Report 2018
UAE, with one of the highest rates of Type 2 diabetes represents significant societal costs, in relation to morbidity, mortality and also lost productivity coupled…
India Specialty Clinics Market Sales Revenue Opportunity Report 2018
Specialty clinics are emerging out of the general hospitals as a universal trend. Globally, niche specialties are being catered to by specialty clinics. The share…
South Korea Biosimilar Market Sales Revenue Opportunity Report
South Korea has emerged as one of the strategic location for the development of biosimilars on the global level. Among the various emerging countries identified…
Global Orphan Drug Market Sales Revenue Opportunity Report 2018
The global pharmaceutical industry has been experiencing a slow growth in recent years owing to many factors such as expiration of patents, competition from generic…
US Cancer Vaccine Market Sales Revenue Opportunity Report 2018
Cancer vaccines are a viable option for treating many types of cancers which in the present day do not have effective treatments. Therapeutic cancer vaccines…
Europe Orphan Drug Market Sales Revenue Opportunity Report 2018
The concept of rare diseases and the idea that a special attention needs to be given to this sector has been taking shape in Europe…
US Proton Therapy Market Sales Revenue Opportunity Report
Proton beam therapy is seen as the next great leap forward in treating cancer with radiation. It has been found that proton therapy is beneficial…
